Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Cerus Corporation

< Previous 1 2 Next >
Cerus Corporation Announces Third Quarter 2024 Financial Results
From Cerus Corporation
Via Business Wire
Tickers CERS
Cerus Corporation to Release Third Quarter 2024 Financial Results on October 30, 2024
From Cerus Corporation
Via Business Wire
Tickers CERS
Cerus Corporation Announces Workshop and Abstracts at the 2024 AABB Annual Meeting
From Cerus Corporation
Via Business Wire
Tickers CERS
Cerus Corporation Provides Updates on INTERCEPT Red Blood Cell Programs in the U.S. and Europe
From Cerus Corporation
Via Business Wire
Tickers CERS
Cerus Corporation Announces Second Quarter 2024 Financial Results and Increases Full-Year 2024 Product Revenue Guidance Range
From Cerus Corporation
Via Business Wire
Tickers CERS
Cerus Corporation to Release Second Quarter 2024 Financial Results on August 1, 2024
From Cerus Corporation
Via Business Wire
Tickers CERS
Cerus Corporation Announces Appointment of Dean Gregory to Board of Directors
From Cerus Corporation
Via Business Wire
Tickers CERS
Cerus Corporation Announces Symposium and Abstracts at the 38th International Congress of the International Society of Blood Transfusion
From Cerus Corporation
Via Business Wire
Tickers CERS
Cerus Corporation Celebrates World Blood Donor Day 2024
From Cerus Corporation
Via Business Wire
Tickers CERS
Cerus Corporation to Participate in 21st Annual Craig-Hallum Institutional Investor Conference
From Cerus Corporation
Via Business Wire
Tickers CERS
Cerus Corporation Announces First Quarter 2024 Financial Results
From Cerus Corporation
Via Business Wire
Tickers CERS
Cerus Corporation to Release First Quarter 2024 Financial Results on May 2, 2024
From Cerus Corporation
Via Business Wire
Tickers CERS
Cerus Corporation Announces FDA Approval of Extended Shelf Life for INTERCEPT Platelet Processing Sets – Doubling Previous Shelf Life
From Cerus Corporation
Via Business Wire
Tickers CERS
Cerus Corporation Announces Positive Topline Results for the Phase 3 Clinical Trial of the INTERCEPT Blood System for Red Blood Cells in Cardiovascular Surgery Patients
From Cerus Corporation
Via Business Wire
Tickers CERS
Cerus Corporation Announces Fourth Quarter and Full-Year 2023 Financial Results
From Cerus Corporation
Via Business Wire
Tickers CERS
Cerus Corporation to Release Fourth Quarter and Full-Year 2023 Financial Results on March 5, 2024
From Cerus Corporation
Via Business Wire
Tickers CERS
Cerus Corporation to Participate in Upcoming Investor Conferences
From Cerus Corporation
Via Business Wire
Tickers CERS
Cerus Corporation Announces Preliminary Fourth Quarter and Full-Year 2023 Product Revenue and Provides Business Update
From Cerus Corporation
Via Business Wire
Tickers CERS
Cerus Corporation to Participate in Upcoming Investor Conferences
From Cerus Corporation
Via Business Wire
Tickers CERS
Cerus Corporation Announces Third Quarter 2023 Financial Results
From Cerus Corporation
Via Business Wire
Tickers CERS
Cerus Corporation to Release Third Quarter 2023 Financial Results on November 2, 2023
From Cerus Corporation
Via Business Wire
Tickers CERS
Cerus Corporation Announces Workshop and Abstracts at the 2023 AABB Annual Meeting
From Cerus Corporation
Via Business Wire
Tickers CERS
Cerus Corporation Announces the Appointment of Alicia Goodman as New Chief Human Resources Officer
From Cerus Corporation
Via Business Wire
Tickers CERS
Cerus Corporation to Participate in the 2023 Cantor Global Healthcare Conference
From Cerus Corporation
Via Business Wire
Tickers CERS
Cerus Corporation Announces Second Quarter 2023 Financial Results
From Cerus Corporation
Via Business Wire
Tickers CERS
Cerus Corporation to Release Second Quarter 2023 Financial Results on August 2, 2023
From Cerus Corporation
Via Business Wire
Tickers CERS
Cerus Corporation Announces Symposium and Abstracts at the 33rd Regional ISBT Congress
From Cerus Corporation
Via Business Wire
Tickers CERS
Cerus Corporation Celebrates World Blood Donor Day 2023
From Cerus Corporation
Via Business Wire
Tickers CERS
Cerus Corporation Announces Follow-on Award of U.S. Department of Defense Funding for Development of Pathogen Reduced, Lyophilized Cryoprecipitate
From Cerus Corporation
Via Business Wire
Tickers CERS
Cerus Corporation Announces First Quarter 2023 Financial Results
From Cerus Corporation
Via Business Wire
Tickers CERS
< Previous 1 2 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.